Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Trex Bio, Inc.
13G
TRXB · 89531N100
|
7.2% |
10/16/2026
Event 10/8/2026
|
|||
| Pfizer Inc. (13-5315170) | 7.2% | ||||
| Pfizer Ventures (US) LLC (82-5524518) | 4.6% | ||||
|
ORIC Pharmaceuticals, Inc.
13G/A
ORIC · 68622P109
|
3.3% |
5/12/2026
Event 3/31/2026
|
|||
|
Allogene Therapeutics, Inc.
13D/A
ALLO · 019770106
|
9.0% |
2/13/2026
Event 11/6/2025
|
|||
|
Q32 Bio Inc.
13G/A
QTTB · 746964105
|
2.3% |
2/13/2026
Event 12/31/2024
|
|||
|
Nextcure, Inc.
13G/A
NXTC · 65343E108
|
3.0% |
2/13/2026
Event 12/31/2025
|
|||
| Pfizer Inc. (IRS Identification No.: 13-5315170) | 3.0% | ||||
| Pfizer Ventures (US) LLC (IRS Indentification No. 82-5524518 ) | 2.5% | ||||
|
Haleon plc
13D/A
HLN · 405552100
|
0% |
3/24/2025
Event 3/21/2025
|
|||
|
Zura Bio Limited
13G/A
ZURA · G9TY5A101
|
4.6% |
2/12/2025
Event 12/31/2024
|
|||
|
Cardiff Oncology, Inc.
13G/A
CRDF · 14147L108
|
3.6% |
2/12/2025
Event 12/31/2024
|
|||